EP Patent

EP3412661A1 — Cocrystals of vortioxetine hydrobromide and resorcinol

Assigned to Enantia SL · Expires 2018-12-12 · 7y expired

What this patent protects

Cocrystals of vortioxetine hydrobromide and resorcinol, their preparation processes, as well as pharmaceutical compositions comprising them. The cocrystals are useful as active pharmaceutical ingredients of medicaments for the treatment of major depressive disorder.

USPTO Abstract

Cocrystals of vortioxetine hydrobromide and resorcinol, their preparation processes, as well as pharmaceutical compositions comprising them. The cocrystals are useful as active pharmaceutical ingredients of medicaments for the treatment of major depressive disorder.

Drugs covered by this patent

Patent Metadata

Patent number
EP3412661A1
Jurisdiction
EP
Classification
—
Expires
2018-12-12
Drug substance claim
No
Drug product claim
No
Assignee
Enantia SL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.